{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:08Z","timestamp":1792724948096,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jpba.2025.117189","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:37:45Z","timestamp":1760197065000},"page":"117189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome"],"prefix":"10.1016","volume":"268","author":[{"given":"Zeynep","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Yayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8250-7520","authenticated-orcid":false,"given":"Zeynep","family":"Turkmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117189_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1108\/APJML-11-2012-0121","article-title":"Understanding counterfeit consumption","volume":"26","author":"Tang","year":"2014","journal-title":"Asia Pac.J. Mark. Logist."},{"key":"10.1016\/j.jpba.2025.117189_bib2","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1002\/jps.22679","article-title":"The global counterfeit drug trade: patient safety and public health risks","volume":"100","author":"Mackey","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117189_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.15406\/frcij.2018.06.00200","article-title":"Counterfeit drugs and the online pharmaceutical trade: a threat to public safety","volume":"6","author":"O\u2019Hagan","year":"2018","journal-title":"Forensic Res. Criminol. Int. J."},{"key":"10.1016\/j.jpba.2025.117189_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.17986\/blm.2014191770","article-title":"Forensic and legal aspect of the contents of herbal and supplementary products","volume":"19","author":"T\u00fcrkmen","year":"2014","journal-title":"Bull. Leg. Med."},{"key":"10.1016\/j.jpba.2025.117189_bib5","series-title":"Global surveillance and monitoring system for substandard and falsified medical products","first-page":"3","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.jpba.2025.117189_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0738.84191","article-title":"Counterfeit herbal Medicine","volume":"1","author":"Mullaicharam","year":"2011","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."},{"key":"10.1016\/j.jpba.2025.117189_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpba.2013.01.009","article-title":"Understanding and fighting the Medicine counterfeit market","volume":"87","author":"D\u00e9gardin","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117189_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2125.2011.04135.x","article-title":"Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong","volume":"73","author":"Ching","year":"2012","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117189_bib9","article-title":"An authenticity survey of herbal medicines from markets in China using DNA barcoding","volume":"6","author":"Han","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2025.117189_bib10","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3389\/fphar.2019.01227","article-title":"The DNA-based authentication of commercial herbal products reveals their globally widespread adulteration","volume":"10","author":"Ichim","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2025.117189_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006290","article-title":"Interventions to combat or prevent drug counterfeiting: a systematic review","volume":"5","author":"El-Jardali","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpba.2025.117189_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpba.2005.12.015","article-title":"Application of LC\u2013ESI\u2013MS\u2013MS for detection of synthetic adulterants in herbal remedies","volume":"41","author":"Bogusz","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117189_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4269\/ajtmh.14-0389","article-title":"Counterfeit drug penetration into global legitimate Medicine supply chains: a global assessment","volume":"92","author":"Mackey","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jpba.2025.117189_bib14","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/00450618.2016.1273387","article-title":"Identification of undeclared active pharmaceutical ingredients in counterfeit herbal medicines used as opioid substitution therapy","volume":"49","author":"Foroughi","year":"2017","journal-title":"Aust. J. Forensic Sci."},{"key":"10.1016\/j.jpba.2025.117189_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4103\/2249-4863.201175","article-title":"A study on alcohol use and its related health and social problems in rural puducherry, India","volume":"5","author":"Ramanan","year":"2016","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.jpba.2025.117189_bib16","article-title":"Alcohol withdrawal syndrome: benzodiazepines and beyond","volume":"9","author":"Sachdeva","year":"2015","journal-title":"J. Clin. Diagn. Res"},{"key":"10.1016\/j.jpba.2025.117189_bib17","series-title":"Clinical Pharmacology","first-page":"311","article-title":"Psychotropic drugs","author":"Nutt","year":"2012"},{"key":"10.1016\/j.jpba.2025.117189_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1527-3458.2004.tb00028.x","article-title":"The pharmacology of chlormethiazole: a potential neuroprotective agent?","volume":"10","author":"Wilby","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jpba.2025.117189_bib19","first-page":"225","article-title":"Deaths in connection with chlormethiazole (heminevrin) therapy","volume":"14","author":"Pentik\u00e4inen","year":"1976","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"10.1016\/j.jpba.2025.117189_bib20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1081\/CLT-120026520","article-title":"Comparison of the fatal toxicity index of zopiclone with benzodiazepines","volume":"41","author":"Reith","year":"2003","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.jpba.2025.117189_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.forsciint.2005.05.011","article-title":"Driving under the influence of chlormethiazole","volume":"153","author":"Jones","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.117189_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1192\/bjp.128.4.375","article-title":"Physiological dependence on, and symptoms of withdrawal from, chlormethiazole","volume":"128","author":"Reilly","year":"1976","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpba.2025.117189_bib23","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpba.2025.117189_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0379-0738(01)00455-8","article-title":"Postmortem tissue concentrations of venlafaxine","volume":"121","author":"Goeringer","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.117189_bib25","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/01.JGP.0000204328.50105.b3","article-title":"Cardiovascular changes associated with venlafaxine in the treatment of late-life depression","volume":"14","author":"Johnson","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpba.2025.117189_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1258\/acb.2009.009003","article-title":"Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity","volume":"46","author":"Wijnen","year":"2009","journal-title":"Ann. Clin. Biochem"},{"key":"10.1016\/j.jpba.2025.117189_bib27","first-page":"2","article-title":"Venlafaksin\u2019in major depresyonda etkinli\u011fI ve emniyeti: bir a\u00e7\u0131k \u00e7al\u0131\u015fma","volume":"8","author":"Ebrin\u00e7","year":"1998","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpba.2025.117189_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.forsciint.2011.05.008","article-title":"Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPD","volume":"215","author":"Mastrogianni","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.117189_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.forsciint.2009.12.015","article-title":"Demographics of suicide victims in Sweden in relation to their blood\u2013alcohol concentration and the circumstances and manner of death","volume":"198","author":"Holmgren","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.117189_bib30","series-title":"Drug connected to thoughts about killing","author":"Brown","year":"2006"},{"key":"10.1016\/j.jpba.2025.117189_bib31","first-page":"7","article-title":"Selective serotonin reuptake inhibitor (SSRI) drugs: more risks than benefits","volume":"14","author":"Kauffman","year":"2009","journal-title":"J. Am. Physicians Surg."},{"key":"10.1016\/j.jpba.2025.117189_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/00085030.1998.10757106","article-title":"Possible impairment by venlafaxine: a case report","volume":"31","author":"Malcolm","year":"1998","journal-title":"Can. Soc. Forensic Sci. J."},{"key":"10.1016\/j.jpba.2025.117189_bib33","article-title":"Bir venlafaksin ba\u011f\u0131mL\u0131l\u0131\u011f\u0131 olgusu","volume":"19","author":"E\u015fsizo\u011flu","year":"2009","journal-title":"Bull. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpba.2025.117189_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140702","article-title":"Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: synthesis, characterization and in vitro & in silico biological activity studies","volume":"1322","author":"\u00c7ak\u0131r","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jpba.2025.117189_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpba.2017.03.054","article-title":"Monitoring drug\u2013serum protein interactions for early ADME prediction through surface plasmon resonance technology","volume":"144","author":"Fabini","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117189_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140937","article-title":"New 4-methanesulfonyloxy benzohydrazide derivatives as potential antioxidant and carbonic anhydrase I and II inhibitors: synthesis, characterization, molecular docking, dynamics & ADME studies","volume":"1325","author":"K\u00f6se","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jpba.2025.117189_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfca.2024.106682","article-title":"1-Benzhydryl-piperazine: isolation, structure determination, and in silico studies for a novel potential narcotic agent detected in sports supplements","author":"Arslan","year":"2024","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.jpba.2025.117189_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific working group for forensic toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","author":"Scientific Working Group for Forensic Toxicology (SWGTOX)","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2025.117189_bib39","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1520\/JFS14801J","article-title":"A mixed-drug intoxication involving venlafaxine and verapamil","volume":"45","author":"Kunsman","year":"2000","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.jpba.2025.117189_bib40","first-page":"153","article-title":"Multiple complications and withdrawal syndrome associated with quetiapine\/venlafaxine intoxication","volume":"39","author":"Pr\u00e9court","year":"2005","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.jpba.2025.117189_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12024-019-00097-3","article-title":"Fatal overdose with a combination of SNRIs venlafaxine and duloxetine","volume":"15","author":"Alibegovi\u0107","year":"2019","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.jpba.2025.117189_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/ther.2014.0030","article-title":"Successful use of therapeutic hypothermia after cardiac arrest due to amitriptyline and venlafaxine intoxication","volume":"5","author":"Kontio","year":"2015","journal-title":"Ther. Hypothermia Temp. Manag"},{"issue":"2","key":"10.1016\/j.jpba.2025.117189_bib43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2125.2007.02849.x","article-title":"Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases","volume":"64","author":"Howell","year":"2007","journal-title":"Br. J. Clin. Pharm."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:22:56Z","timestamp":1766503376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0731708525005308"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117189","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117189"}}